Evidence map›Paper›PMID 36479570›Full record

ReviewFrontiers in cardiovascular medicine2022

A 20-year journey in transcatheter aortic valve implantation: Evolution to current eminence.

Andreas S Kalogeropoulos, Simon R Redwood, Christopher J Allen, Harriet Hurrell, Omar Chehab, Ronak Rajani, Bernard Prendergast, Tiffany Patterson

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in cardiovascular medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
7.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 49 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. TAVI Through the Years: A Systematic Review of Progress.Journal of pharmacy & bioallied sciences · 2025
    Review
  13. Transcatheter Aortic Valve Replacement Sizing: Getting It Right.Structural heart : the journal of the Heart Team · 2025
    Article
  14. Transcatheter aortic valve replacement in heavily calcified aortic valve stenosis: a multicenter comparison.Clinical research in cardiology : official journal of the German Cardiac Society · 2025
    Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Long-Term Outcomes of Transcatheter vs Surgical Aortic Valve Replacement: Meta-analysis of Randomized Trials.Journal of the Society for Cardiovascular Angiography & Interventions · 2024
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Andreas S KalogeropoulosSt. Thomas' Hospital, Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom.
Simon R RedwoodSt. Thomas' Hospital, Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom.
Christopher J AllenSt. Thomas' Hospital, Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom.
Harriet HurrellSt. Thomas' Hospital, Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom.
Omar ChehabSt. Thomas' Hospital, Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom.
Ronak RajaniSt. Thomas' Hospital, Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom.
Bernard PrendergastSt. Thomas' Hospital, Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom.
Tiffany PattersonSt. Thomas' Hospital, Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom.
Guy's and St Thomas' NHS Foundation Trust · GBSt Thomas' Hospital · GBKing's College London · GB

Funding

British Heart Foundation FS/CRTF/22/24312
6 · The paper itself

Abstract

Since the first groundbreaking procedure in 2002, transcatheter aortic valve implantation (TAVI) has revolutionized the management of aortic stenosis (AS). Through striking developments in pertinent equipment and techniques, TAVI has now become the leading therapeutic strategy for aortic valve replacement in patients with severe symptomatic AS. The procedure streamlining from routine use of conscious sedation to a single arterial access approach, the newly adapted implantation techniques, and the introduction of novel technologies such as intravascular lithotripsy and the refinement of valve-bioprosthesis devices along with the accumulating experience have resulted in a dramatic reduction of complications and have improved associated outcomes that are now considered comparable or even superior to surgical aortic valve replacement (SAVR). These advances have opened the road to the use of TAVI in younger and lower-risk patients and up-to-date data from landmark studies have now established the outstanding efficacy and safety of TAVI in patients with low-surgical risk impelling the most recent ESC guidelines to propose TAVI, as the main therapeutic strategy for patients with AS aged 75 years or older. In this article, we aim to summarize the most recent advances and the current clinical aspects involving the use of TAVI, and we also attempt to highlight impending concerns that need to be further addressed.

Indexed as

aortic stenosis (AS)aortic valve calcificationbicuspid and tricuspid aortic valveminimalistic approachparavalvular aortic leakTAVITAVR

Identifiers

PMID36479570
PMCPMC9719928
OpenAlexW4309740540

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.